Aron Popovtzer

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3K citations · Full text

Neoadjuvant Therapy, Chemotherapy Versus Cetuximab, Medicine +7

Targeted Gold Nanoparticles Enable Molecular CT Imaging of Cancer

Rachela Popovtzer, Ashish Agrawal, Nicholas A. Kotov et al. · Nano Letters · 2008 · 781 citations · Full text

Nanoparticles, Attenuation Coefficient, Engineering +16

Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells<i>in Vivo</i>with Gold Nanoparticles and CT Imaging

Rinat Meir, Katerina Shamalov, Oshra Betzer et al. · ACS Nano · 2015 · 238 citations

Engineering, Immunology, Immunoediting +16

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 174 citations · Full text

Concurrent Chemoradiotherapy, Neoadjuvant Therapy, Squamous Cell Carcinoma +6

Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

Ravindra Uppaluri, Robert I. Haddad, Yungan Tao et al. · New England Journal of Medicine · 2025 · 153 citations